Collin Ewald is a Swiss researcher specializing in diseases of aging and regenerative medicine at Novartis. He holds executive roles as Vice President and President of two organizations. His work spans longevity interventions and extracellular matrix homeostasis, supported by extensive research and publications. Ewald also contributes as a guest editor for a scientific journal focusing on aging and circadian biology.

‌